CSPC Pharmaceutical Group Limited
(Incorporated in Hong Kong with limited liability)

Announcements & Notices       

2019-December-30	VOLUNTARY ANNOUNCEMENT - TERMINATION OF PRODUCT CO-DEVELOPMENT AND STRATEGIC COLLABORATION AGREEMENT (in PDF)
2019-December-30	VOLUNTARY ANNOUNCEMENT - THE GROUP'S "PREGABALIN CAPSULES" WAS GRANTED THE U.S. ANDA APPROVAL (in PDF)
2019-December-20	VOLUNTARY ANNOUNCEMENT - NEW DRUG APPROVAL OF THE GROUP'S "LEVOAMLODIPINE MALEATE TABLETS" GRANTED BY THE U.S. FDA (in PDF)
2019-December-11	VOLUNTARY ANNOUNCEMENT - PASSING OF CONSISTENCY EVALUATION FOR THE GROUP'S "IBUPROFEN TABLETS" (in PDF)
2019-December-9	REVISION OF ANNUAL CAPS FOR EXISTING CONTINUING CONNECTED TRANSACTIONS (in PDF)
2019-November-27	VOLUNTARY ANNOUNCEMENT - PASSING OF CONSISTENCY EVALUATION FOR THE GROUP'S "CEFIXIME CAPSULES" (in PDF)
2019-November-27	VOLUNTARY ANNOUNCEMENT - SUBMISSION OF CLINICAL TRIAL APPLICATION FOR INVESTIGATIONAL FIRST-IN-CLASS NEW DRUG ALMB-0168 IN AUSTRALIA (in PDF)
2019-November-18	QUARTERLY RESULTS FOR THE NINE MONTHS ENDED 30 SEPTEMBER 2019 (in PDF)
2019-November-7	VOLUNTARY ANNOUNCEMENT - PRODUCT TRANSFER AGREEMENT (in PDF)
2019-November-6	DATE OF BOARD MEETING (in PDF)
2019-November-1	VOLUNTARY ANNOUNCEMENT - PASSING OF CONSISTENCY EVALUATION FOR THE GROUP'S "CEPHALEXIN CAPSULES" (in PDF)
2019-November-1	VOLUNTARY ANNOUNCEMENT - PASSING OF CONSISTENCY EVALUATION FOR THE GROUP'S "CLINDAMYCIN HYDROCHLORIDE CAPSULES" (in PDF)
2019-November-1	VOLUNTARY ANNOUNCEMENT - PASSING OF CONSISTENCY EVALUATION FOR THE GROUP'S "ENALAPRIL MALEATE TABLETS" (in PDF)
2019-October-31	VOLUNTARY ANNOUNCEMENT - PASSING OF CONSISTENCY EVALUATION FOR THE GROUP'S "IBUPROFEN GRANULES" (in PDF)
2019-October-31	VOLUNTARY ANNOUNCEMENT - "RECOMBINANT ANTI-EpCAM AND ANTI-CD3 HUMAN-MOUSE CHIMERIC BISPECIFIC ANTIBODY FOR INJECTION" WAS GRANTED CLINICAL TRIAL APPROVAL BY U.S. FDA (in PDF)
2019-October-29	VOLUNTARY ANNOUNCEMENT - DRUG REGISTRATION APPROVAL OF THE GROUP'S "DRONEDARONE HYDROCHLORIDE TABLET" (in PDF)
2019-October-27	INSIDE INFORMATION - PRINCIPAL ACCOUNTING DATA AND FINANCIAL INDICATORS OF CSPC INNOVATION PHARMACEUTICAL CO., LTD. FOR THE NINE MONTHS ENDED 30 SEPTEMBER 2019 (in PDF)
2019-October-22	VOLUNTARY ANNOUNCEMENT - ANTI-TUMOR NANODRUG "EPIRUBICIN HYDROCHLORIDE LIPOSOME INJECTION" WAS GRANTED CLINICAL TRIAL APPROVAL (in PDF)
2019-October-21	VOLUNTARY ANNOUNCEMENT - INVESTIGATIONAL NEW DRUG ALMB-0166 WAS GRANTED CLINICAL TRIAL APPROVAL IN AUSTRALIA (in PDF)
2019-October-18	VOLUNTARY ANNOUNCEMENT - FIRST-IN-CLASS PRODUCT CANDIDATE ALMB-0168 GRANTED RARE PEDIATRIC DISEASE DESIGNATION BY THE U.S. FDA (in PDF)
2019-October-14	INSIDE INFORMATION - ANNOUNCEMENT ON THE INDICATIVE RESULTS FOR THE NINE MONTHS ENDED 30 SEPTEMBER 2019 OF CSPC INNOVATION PHARMACEUTICAL CO., LTD. (in PDF)
2019-September-26	VOLUNTARY ANNOUNCEMENT - DRUG REGISTRATION APPROVAL OF THE GROUP'S "GLUTATHIONE FOR INJECTION" (in PDF)
2019-September-26	VOLUNTARY ANNOUNCEMENT - DRUG REGISTRATION APPROVAL OF THE GROUP'S "METFORMIN HYDROCHLORIDE EXTENDED-RELEASE TABLETS" (in PDF)
2019-September-23	FIRST-IN-CLASS PRODUCT CANDIDATE ALMB-0168 WAS GRANTED ORPHAN-DRUG DESIGNATION BY THE U.S. FDA (in PDF)
2019-September-10	VOLUNTARY ANNOUNCEMENT - PASSING OF CONSISTENCY EVALUATION FOR THE GROUP'S "CEFUROXIME AXETIL TABLETS" (in PDF)
2019-September-2	VOLUNTARY ANNOUNCEMENT - RECOMBINANT ANTI-HER2 AND ANTI-CD3 HUMANIZED BISPECIFIC ANTIBODY FOR INJECTION WAS GRANTED CLINICAL TRIAL APPROVAL BY U.S. FDA (in PDF)
2019-August-21	VOLUNTARY ANNOUNCEMENT - NEW TARGET ANTI-TUMOR DRUG "SYHA1801" WAS GRANTED CLINICAL TRIAL APPROVAL (in PDF)
2019-August-19	VOLUNTARY ANNOUNCEMENT - PRODUCT LICENSING AND COMMERCIALIZATION AGREEMENT (in PDF)
2019-August-19	2019 INTERIM RESULTS ANNOUNCEMENT (in PDF)
2019-August-18	INSIDE INFORMATION - PRINCIPAL ACCOUNTING DATA AND FINANCIAL INDICATORS OF CSPC INNOVATION PHARMACEUTICAL CO., LTD.* FOR THE HALF YEAR ENDED 30 JUNE 2019 (in PDF)
2019-August-15	VOLUNTARY ANNOUNCEMENT - SUBMISSION OF CLINICAL TRIAL APPLICATION FOR INVESTIGATIONAL FIRST-IN-CLASS NEW DRUG ALMB-0166 IN AUSTRALIA (in PDF)
2019-August-7	DATE OF BOARD MEETING (in PDF)
2019-July-29	VOLUNTARY ANNOUNCEMENT - NEW TARGET ANTI-TUMOR DRUG "SYHA1807" WAS GRANTED CLINICAL TRIAL APPROVAL (in PDF)
2019-July-12	INSIDE INFORMATION - ANNOUNCEMENT ON THE INDICATIVE RESULTS FOR THE HALF YEAR ENDED 30 JUNE 2019 OF CSPC INNOVATION PHARMACEUTICAL CO., LTD.* (in PDF)
2019-July-12	CONTINUING CONNECTED TRANSACTIONS - RENEWAL OF STEAM SUPPLY AGREEMENT (in PDF)
2019-July-2	CHANGE OF ADDRESS OF SHARE REGISTRAR AND TRANSFER OFFICE (in PDF)
2019-June-25	CONNECTED TRANSACTIONS - LEASE AGREEMENTS (in PDF)
2019-June-13	VOLUNTARY ANNOUNCEMENT - DRUG REGISTRATION APPROVAL OF THE GROUP'S "TICAGRELOR TABLETS" (in PDF)
2019-June-10	VOLUNTARY ANNOUNCEMENT - DRUG REGISTRATION APPROVAL OF THE GROUP'S "CLOPIDOGREL BISULFATE TABLETS" (in PDF)
2019-May-27	POLL RESULTS OF ANNUAL GENERAL MEETING HELD ON 27 MAY 2019 (in PDF)
2019-May-21	LIST OF DIRECTORS AND THEIR ROLE AND FUNCTION (in PDF)
2019-May-21	CHANGE OF VICE-CHAIRMAN AND ROTATING CHIEF EXECUTIVE OFFICER (in PDF)
2019-May-21	QUARTERLY RESULTS FOR THE THREE MONTHS ENDED 31 MARCH 2019 (in PDF)
2019-May-8	DATE OF BOARD MEETING (in PDF)
2019-May-7	VOLUNTARY ANNOUNCEMENT - FORMATION OF JOINT VENTURE (in PDF)
2019-April-28	INSIDE INFORMATION - PRINCIPAL ACCOUNTING DATA AND FINANCIAL INDICATORS OF CSPC INNOVATION PHARMACEUTICAL CO., LTD .* FOR THE THREE MONTHS ENDED 31 MARCH 2019 (in PDF)
2019-April-25	VOLUNTARY ANNOUNCEMENT - "PACLITAXEL CATIONIC LIPOSOME FOR INJECTION" FOR THE TREATMENT OF BREAST CANCER WAS GRANTED CLINICAL TRIAL APPROVAL (in PDF)
2019-April-25	VOLUNTARY ANNOUNCEMENT - NEW ORAL ANTI-COAGULANT DRUG "SYHA136" WAS GRANTED CLINICAL TRIAL APPROVAL (in PDF)
2019-April-17	NOTICE OF ANNUAL GENERAL MEETING (in PDF)
2019-April-12	VOLUNTARY ANNOUNCEMENT - "SYHA1803" FOR THE TREATMENT OF INTRAHEPATIC CHOLANGIOCARCINOMA AND UROTHELIAL CARCINOMA WAS GRANTED CLINICAL TRIAL APPROVAL (in PDF)
2019-April-12	VOLUNTARY ANNOUNCEMENT - "SYHA1402" FOR THE TREATMENT OF DIABETIC NEUROPATHY WAS GRANTED CLINICAL TRIAL APPROVAL (in PDF)
2019-March-21	UPDATES ON THE SPIN-OFF AND SEPARATE LISTING OF CSPC XNW GROUP ON THE CHINEXT OF SHENZHEN STOCK EXCHANGE (in PDF)
2019-March-18	ANNUAL RESULTS FOR THE YEAR ENDED 31 DECEMBER 2018 (in PDF)
2019-March-6	DATE OF BOARD MEETING (in PDF)
2019-March-5	VOLUNTARY ANNOUNCEMENT - SUBMISSION OF NDA TO U.S. FDA FOR LEVOAMLODIPINE MALEATE TABLETS (in PDF)
2019-March-5	PROGRESS UPDATE ON THE PROPOSED SPIN-OFF AND SEPARATE LISTING OF CSPC XNW GROUP ON THE SHENZHEN STOCK EXCHANGE (in PDF)
2019-March-3	PROGRESS UPDATE ON THE PROPOSED SPIN-OFF AND SEPARATE LISTING OF CSPC XNW GROUP ON THE SHENZHEN STOCK EXCHANGE (in PDF)
2019-February-26	VOLUNTARY ANNOUNCEMENT - PRODUCT CO-DEVELOPMENT AND COMMERCIALIZATION AGREEMENTS (in PDF)
2019-January-15	GRANT OF SHARES PURSUANT TO THE SHARE AWARD SCHEME OF THE COMPANY (in PDF)
2019-January-10	UNUSUAL PRICE AND TRADING VOLUME MOVEMENT (in PDF)
2019-January-7	VOLUNTARY ANNOUNCEMENT - ACQUISITION OF 100% INTEREST IN YONG SHUN TECHNOLOGY DEVELOPMENT LIMITED (in PDF)
2019-January-4	VOLUNTARY ANNOUNCEMENT - PRODUCT CO-DEVELOPMENT AND STRATEGIC COLLABORATION AGREEMENT (in PDF)
2024	2024 Announcements & Notices
2023	2023 Announcements & Notices
2022	2022 Announcements & Notices
2021	2021 Announcements & Notices
2020	2020 Announcements & Notices
2018	2018 Announcements & Notices
2017	2017 Announcements & Notices
2016	2016 Announcements & Notices
2015	2015 Announcements & Notices
2014	2014 Announcements & Notices
2013	2013 Announcements & Notices
2012	2012 Announcements & Notices
2011	2011 Announcements & Notices
2010	2010 Announcements & Notices
2009	2009 Announcements & Notices
2008	2008 Announcements & Notices
2007	2007 Announcements & Notices
2006	2006 Announcements & Notices